8247 — BioSino Bio-technology and Science Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$101.30m
- HK$219.40m
- CNY289.07m
- 15
- 67
- 14
- 18
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | HKAS | HKAS | HKAS | HKAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -115 | 2.15 | 6.41 | 18.5 | -17.6 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 129 | -10.1 | 22 | 5.26 | -0.102 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -16.5 | -6.01 | -7.41 | -2.97 | -8.48 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 31.4 | 11.4 | 48.9 | 44.5 | -6.56 |
Capital Expenditures | -18.3 | -16 | -6.55 | -16.5 | -16.6 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 69.6 | 0.015 | 0.771 | 15.4 | -1.12 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 51.3 | -15.9 | -5.78 | -1.12 | -17.7 |
Financing Cash Flow Items | -15.8 | -11.8 | -10.6 | 14.9 | 11.1 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -71.1 | 20.5 | -44 | -10.8 | 10.2 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 11.8 | 15.4 | -0.984 | 32.9 | -13.9 |